Pipeline | Development Phase | ||||
---|---|---|---|---|---|
Hit to Lead | Candidate | Preclinical | Phase 1 | ||
Neurodegenerative disease | EFL-101 |
|
|||
Incurable disease | EFL-301 |
|
|||
Musculoskeletal disease | EFL-501 |
|
|||
EFL-601 |
|
||||
Sensory organ disease | EFL-201 |
|
|||
EFL-901 |
|
||||
EFL-1101 |
|
Development Phase | |||
---|---|---|---|
Hit to Lead | Candidate | Preclinical | Phase 1 |
|
Development Phase | |||
---|---|---|---|
Hit to Lead | Candidate | Preclinical | Phase 1 |
|
Development Phase | |||
---|---|---|---|
Hit to Lead | Candidate | Preclinical | Phase 1 |
|
Development Phase | |||
---|---|---|---|
Hit to Lead | Candidate | Preclinical | Phase 1 |
|
Development Phase | |||
---|---|---|---|
Hit to Lead | Candidate | Preclinical | Phase 1 |
|
Development Phase | |||
---|---|---|---|
Hit to Lead | Candidate | Preclinical | Phase 1 |
|
Development Phase | |||
---|---|---|---|
Hit to Lead | Candidate | Preclinical | Phase 1 |
|